NM_145207.3:c.1365G>A
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_145207.3(AFG2A):c.1365G>A(p.Leu455Leu) variant causes a synonymous change. The variant allele was found at a frequency of 0.0000528 in 1,608,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L455L) has been classified as Likely benign.
Frequency
Consequence
NM_145207.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, PanelApp Australia
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AFG2A | NM_145207.3 | c.1365G>A | p.Leu455Leu | synonymous_variant | Exon 8 of 16 | ENST00000274008.5 | NP_660208.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AFG2A | ENST00000274008.5 | c.1365G>A | p.Leu455Leu | synonymous_variant | Exon 8 of 16 | 1 | NM_145207.3 | ENSP00000274008.3 | ||
| AFG2A | ENST00000422835.2 | n.1407G>A | non_coding_transcript_exon_variant | Exon 8 of 15 | 1 | |||||
| AFG2A | ENST00000675612.1 | c.1362G>A | p.Leu454Leu | synonymous_variant | Exon 8 of 17 | ENSP00000502453.1 | ||||
| AFG2A | ENST00000674886.1 | n.1427G>A | non_coding_transcript_exon_variant | Exon 8 of 11 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152096Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000523 AC: 13AN: 248412 AF XY: 0.0000447 show subpopulations
GnomAD4 exome AF: 0.0000522 AC: 76AN: 1456884Hom.: 0 Cov.: 30 AF XY: 0.0000469 AC XY: 34AN XY: 724504 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152096Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74302 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
AFG2A: BP4, BP7
not specified Benign:1
Variant summary: AFG2A c.1365G>A alters a conserved nucleotide resulting in a synonymous change. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 5e-05 in 279810 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in AFG2A causing Epilepsy, Hearing Loss, And Mental Retardation Syndrome, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.1365G>A in individuals affected with Epilepsy, Hearing Loss, And Mental Retardation Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 542393). Based on the evidence outlined above, the variant was classified as likely benign.
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at